Entrada Therapeutics (TRDA)
(Delayed Data from NSDQ)
$14.19 USD
+0.14 (1.00%)
Updated May 14, 2024 04:00 PM ET
After-Market: $14.18 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.25 | 40.13% |
Earnings Summary
For their last quarter, Entrada Therapeutics (TRDA) reported earnings of $0.68 per share, beating the Zacks Consensus Estimate of $-0.38 per share. This reflects a positive earnings surprise of 278.95%. Look out for TRDA's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.25 per share, reflecting a year-over-year increase of 132.05%.
Earnings History
Price & Consensus
Zacks News for TRDA
Exelixis (EXEL) Posts Preliminary 2023 Results, to Cut 13% Jobs
TRDA: What are Zacks experts saying now?
Zacks Private Portfolio Services